Evaluating the impact of the COVID-19 pandemic on cancer control in Manitoba

  • Funded by Canadian Institutes of Health Research (CIHR)
  • Total publications:0 publications

Grant number: 202111WI1

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2021
    2023
  • Known Financial Commitments (USD)

    $347,119.68
  • Funder

    Canadian Institutes of Health Research (CIHR)
  • Principal Investigator

    N/A

  • Research Location

    Canada
  • Lead Research Institution

    University of Manitoba
  • Research Priority Alignment

    N/A
  • Research Category

    Secondary impacts of disease, response & control measures

  • Research Subcategory

    Indirect health impacts

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Cancer is the leading cause of death in Canada. The cancer care system aims to lessen this burden by improving survival through screening, early detection and diagnosis, and timely, high quality treatment. However, the COVID-19 pandemic has had a significant impact on cancer care. In Manitoba, several interventions were implemented by CancerCare Manitoba (CCMB) (the provincial agency responsible for cancer screening and treatment) to keep cancer patients safe while continuing to provide excellent care. These interventions included changes to cancer screening programs, shifts from in-person visits to telephone visits, prioritizing the most critical cancer surgeries, and altering how chemotherapy and radiotherapy were delivered. The overall goal of this project is to understand how the COVID-19 pandemic and the interventions that were implemented to reduce its impact affected cancer services and outcomes such as survival in Manitoba.